SCHEMBL17224809

SCHEMBL17224809

ClC(Cl)C(Cl)c1cccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
CYP1A2 P05177 3/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
CYP2A6 P11509 3/20 0.44
ADRA2A P08913 6/20 0.42
ADRA2B P18089 6/20 0.42
ADRA2C P18825 6/20 0.42
ADRA1A P35348 4/20 0.42
ADRA1D P25100 3/20 0.42
ADRA1B P35368 3/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
SLC6A4 P31645 1/20 0.40
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
KEAP1 Q14145 1/20 0.39
ACP3 P15309 1/20 0.39
HPRT1 P00492 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1538545 0.81 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5610173 0.77 CYP1A2 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5609718 0.77 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL6645032 0.77 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL29774251 0.77 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5609722 0.77 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5610170 0.77 ALDH1A1 (0.61) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL2333290 0.77 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL2321827 0.76 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL12880576 0.76 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111018790-B Pyridazinone herbicides FMC公司 2023-09-19 CN disclosed
EP-3865480-A1 HYDRAZINE DERIVATIVES FMC Corporation (US) 2021-08-18 EP disclosed
EP-3137456-B1 PYRIDAZINONE HERBICIDES FMC CORP (US) 2021-06-02 EP disclosed
CN-111018790-A Pyridazinone herbicides FMC公司 2020-04-17 CN disclosed
US-10597388-B2 Pyridazinone herbicides FMC CORPORATION (US) 2020-03-24 US disclosed
CN-106458926-B Pyridazinone herbicides FMC公司 2020-01-03 CN disclosed
US-20190016712-A1 PYRIDAZINONE HERBICIDES FMC CORPORATION 2019-01-17 US disclosed
US-10118917-B2 Pyridazinone herbicides FMC CORPORATION 2018-11-06 US disclosed
EP-3137456-A1 PYRIDAZINONE HERBICIDES E. I. du Pont de Nemours and Company (US) 2017-03-08 EP disclosed
US-20170050953-A1 PYRIDAZINONE HERBICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2017-02-23 US disclosed
CN-106458926-A Pyridazinone herbicides 杜邦公司 2017-02-22 CN disclosed
WO-2015168010-A1 PYRIDAZINONE HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2015-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190016712-A1 PYRIDAZINONE HERBICIDES CBR3, NOX5, NR5A2 ALDH1A1 1685/4885CYP1A2 61/4885CYP2C9 139/4885
US-20170050953-A1 PYRIDAZINONE HERBICIDES CBR3, NOX5, NR5A2 ALDH1A1 1685/4885CYP1A2 61/4885CYP2C9 139/4885
US-10118917-B2 Pyridazinone herbicides CBR3, NOX5, NR5A2 ALDH1A1 1685/4885CYP1A2 61/4885CYP2C9 139/4885
US-10597388-B2 Pyridazinone herbicides CBR3, NOX5, NR5A2 ALDH1A1 1685/4885CYP1A2 61/4885CYP2C9 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.